Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

3-D database search at Schering-Plough leads to potent, selective FPT inhibitors

Sep. 18, 1997

New anthraquinone interacting with telomeric G-quadruplex DNA

Sep. 18, 1997

Genentech discovers new cytokine inducing apoptosis

Sep. 17, 1997

Pharmacia & Upjohn discovers potent camptothecin analogues

Sep. 17, 1997

Preliminary results from phase II/III Sensamide study

Sep. 16, 1997

NCI evaluates stability of SarCNU

Sep. 16, 1997

Cytel and Searle to collaborate on cancer therapies

Sep. 15, 1997

Oncologic Drugs Advisory Committee meets this week

Sep. 15, 1997

Matrix discontinues U.S. development of AccuSite

Sep. 15, 1997

Biricodar dicitrate enters phase II studies in ovarian cancer

Sep. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...